As fears of a pandemic mount, the biotech company’s mRNA vaccine trial is set to release Phase 1/2 results later this year, with a larger Phase 3 trial expected to begin in 2025.
https://www.wired.com/story/moderna-mrna-vaccine-bird-flu-h5n1/?utm_source=dlvr.it&utm_medium=blogger
https://www.wired.com/story/moderna-mrna-vaccine-bird-flu-h5n1/?utm_source=dlvr.it&utm_medium=blogger